Needle moving action has been spotted in Opexa Therapeutics Inc (OPXA) as shares are moving today on volatility -7.69% or $-0.09 from the open. The NASDAQ listed company saw a recent bid of $1.08 and 4841814 shares have traded hands in the session.
Investors might be taking a closer look into the crystal ball to try and decipher what is in store for the second half of the year in the stock market. While cautious optimism may be the prevailing sentiment, many investors will be looking to take the portfolio to the next level. With markets still riding high, the big question is whether the momentum will push stocks higher or if the bears start to take over. There may still be a few undervalued stocks with much more upside potential ready to make big moves. Finding these stocks may involve doing a little more homework. Investors may be looking to take advantage of any little sell-off that might provide some bargain buying opportunities.
Now let’s take a look at how the fundamentals are stacking up for Opexa Therapeutics Inc (OPXA). Fundamental analysis takes into consideration market, industry and stock conditions to help determine if the shares are correctly valued. Opexa Therapeutics Inc currently has a yearly EPS of -1.13. This number is derived from the total net income divided by shares outstanding. In other words, EPS reveals how profitable a company is on a share owner basis.
Another key indicator that can help investors determine if a stock might be a quality investment is the Return on Equity or ROE. Opexa Therapeutics Inc (OPXA) currently has Return on Equity of -129.53. ROE is a ratio that measures profits generated from the investments received from shareholders.
In other words, the ratio reveals how effective the firm is at turning shareholder investment into company profits. A company with high ROE typically reflects well on management and how well a company is run at a high level. A firm with a lower ROE might encourage potential investors to dig further to see why profits aren’t being generated from shareholder money.
Another ratio we can look at is the Return on Invested Capital or more commonly referred to as ROIC. Opexa Therapeutics Inc (OPXA) has a current ROIC of -129.53. ROIC is calculated by dividing Net Income - Dividends by Total Capital Invested.
Similar to ROE, ROIC measures how effectively company management is using invested capital to generate company income. A high ROIC number typically reflects positively on company management while a low number typically reflects the opposite.
Turning to Return on Assets or ROA, Opexa Therapeutics Inc (OPXA) has a current ROA of -87.29. This is a profitability ratio that measures net income generated from total company assets during a given period. This ratio reveals how quick a company can turn it’s assets into profits. In other words, the ratio provides insight into the profitability of a firm’s assets. The ratio is calculated by dividing total net income by the average total assets.
A higher ROA compared to peers in the same industry, would suggest that company management is able to effectively generate profits from their assets. Similar to the other ratios, a lower number might raise red flags about management’s ability when compared to other companies in a similar sector.